title: Measure and interpretation of CF gene therapy trial results.
authors.forename: E
authors.initials: E
authors.lastname: Alton
authors.forename: D
authors.initials: D
authors.lastname: Geddes
authors.forename: D
authors.initials: D
authors.lastname: Gill
authors.forename: A
authors.initials: A
authors.lastname: Greening
authors.forename: C
authors.initials: C
authors.lastname: Higgins
authors.forename: S
authors.initials: S
authors.lastname: Hyde
authors.forename: J A
authors.initials: JA
authors.lastname: Innes
authors.forename: D
authors.initials: D
authors.lastname: Porteous
authors.forename: M
authors.initials: M
authors.lastname: Stern
mesh_terms: D002712:Chlorides / Q000378:metabolism; D002986:Clinical Trials as Topic; D003550:Cystic Fibrosis / Q000628:therapy*; D004134:Dimyristoylphosphatidylcholine / Q000031:analogs & derivatives / Q000494:pharmacology; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D006801:Humans; D008081:Liposomes / Q000235:genetics; D009297:Nasal Mucosa / Q000378:metabolism; D012107:Research Design
chemical_list: C108836:1,2-dimyristoyl-sn-glycero-3-ethylphosphocholine; D002712:Chlorides; D008081:Liposomes; D004134:Dimyristoylphosphatidylcholine